| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 08/28/2002 | CA2373392A1 Palatable pharmaceutical compositions for companion animals |
| 08/27/2002 | US6441163 Methods for preparation of cytotoxic conjugates of maytansinoids and cell binding agents |
| 08/27/2002 | US6441136 Polypeptide of given amino acid sequence, modified by deleting amino acids near binding domains to prevent reaction with polyethylene glycol during conjugation to provide conjugated peptides with no decrease in activity |
| 08/27/2002 | US6441048 Methods of treating affective disorders using derivatives of (-)-venlafaxine |
| 08/27/2002 | US6441040 200 parts s-(3-hydroxypropyl)-l-cysteine, 78 parts corn starch, 1 part talc, and 1 part magnesium stearate does not discolor after 12 months at room temperature, or 3 months at 40 degree c, or 1 month at 50 degree c |
| 08/27/2002 | US6441025 Water soluble paclitaxel derivatives |
| 08/27/2002 | US6441017 Inhibitors of prenyl-protein transferase |
| 08/27/2002 | US6440980 Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs |
| 08/27/2002 | US6440946 Multiple-agents-binding compound, production and use thereof |
| 08/27/2002 | US6440933 Compounds and method for the prevention and treatment of diabetic retinopathy |
| 08/27/2002 | US6440930 Protein formulations |
| 08/27/2002 | US6440929 Pulmonary delivery of active agents |
| 08/27/2002 | US6440743 Supplying immobilizated polynucleotides |
| 08/27/2002 | US6440463 Methods for fine powder formation |
| 08/27/2002 | US6440461 Drug delivery; biocompatibility, biodegradable |
| 08/27/2002 | US6440460 Controlled release; biodegradable; intraocular administering |
| 08/27/2002 | US6440458 Solid solution of tacrolimus or hydrate and hydroxypropyl cellulose |
| 08/27/2002 | US6440454 Supersaturated solution of estradiol, progestogen, and activated silica; outer backing foil and protective lining |
| 08/27/2002 | US6440453 Transdermal systems for release of 5-HT3 receptor antagonists and their use in anti-emetic treatment |
| 08/27/2002 | US6440451 Use of crataegus formulations for prophylaxis and treatment of neoplastic diseases |
| 08/27/2002 | US6440439 Hair treatment compositions |
| 08/27/2002 | US6440430 Oxyalkenylated silicone and silicone oil; stability; drugs, hygiene |
| 08/27/2002 | US6440428 Podophyllotoxin preparation containing triglycerides |
| 08/27/2002 | US6440419 J chain or portion thereof linked to at least one enzyme inhibitor; specifically binds to basolateral factor; eradi-cation of metastatic or nonpolarized cells; lung, breast, colon, ovarian and prostate carcinoma and endometriosis |
| 08/27/2002 | US6440414 Fibrolase and novel acting thrombolytic agents suitable for liquid frozen state or lyophilization storage; metallo-proteinase fibrinolytic agent of seq.id no: 1, zinc stabilizer, buffer and optionally a bulking agent |
| 08/27/2002 | US6440411 Containing algae extract; antiseptic solution |
| 08/27/2002 | US6440393 Sdministering aerosolized drug in an air mixture containing up to about 10% carbon dioxide gas for increasing the deposition of aerosolized drug in the respiratory tract of an individual or animal |
| 08/27/2002 | US6440391 Management of snoring by oral administration of dimethyl sulfone |
| 08/27/2002 | US6439236 Methods for inducing atrial and ventricular rhythms using ultrasound and microbubbles |
| 08/27/2002 | CA2015838C Method of topically treating acne vulgaris |
| 08/22/2002 | WO2002064748A2 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
| 08/22/2002 | WO2002064634A2 Human monoclonal antibodies to fc alpha receptor (cd89) |
| 08/22/2002 | WO2002064616A2 Agonists and antagonists of sphingosine-1-phosphate receptors |
| 08/22/2002 | WO2002064543A2 Novel succinate salt of o-desmethyl-venlafaxine |
| 08/22/2002 | WO2002064168A1 Targetted anti-tumor drug delivery systems |
| 08/22/2002 | WO2002064167A2 Biologically active agents |
| 08/22/2002 | WO2002064166A1 Formulation to enhance bioavailability of bioactive matrials and preparation method thereof |
| 08/22/2002 | WO2002064162A2 Vaccine for transcutaneous immunization |
| 08/22/2002 | WO2002064158A2 Use of a conjugate of il-6 and the receptor thereof for inducing cellular expression of scf and flt-3l |
| 08/22/2002 | WO2002064151A1 Acrochordon alleviation |
| 08/22/2002 | WO2002064148A2 Oral formulations containing mucopolysaccharide for small intestine delivery and their use in the treatment circulatory disorders |
| 08/22/2002 | WO2002064144A1 Aqueous suspension eyedrops and process for producing the same |
| 08/22/2002 | WO2002064133A1 Preparations for controlling concentration in blood |
| 08/22/2002 | WO2002064132A2 Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability |
| 08/22/2002 | WO2002064127A1 Methods and clinical devices for the inhibition or prevention of mammalian cell growth |
| 08/22/2002 | WO2002064124A2 Medicament formulation containing a muscarinic agonist |
| 08/22/2002 | WO2002064122A1 Bioactive and biocompatible conjugates with magnetic properties and a method for producing the same |
| 08/22/2002 | WO2002064121A1 Novel modified released formulation |
| 08/22/2002 | WO2002064119A1 Tablets quickly disintegrated in oral cavity |
| 08/22/2002 | WO2002064118A1 Novel modified release formulation |
| 08/22/2002 | WO2002064116A2 Thermolabile liposome with controlled release temperature |
| 08/22/2002 | WO2002064113A1 Liquid formulations for the prevention and treatment of mucosal diseases and disorders |
| 08/22/2002 | WO2002064111A1 Vitamin/mineral complex |
| 08/22/2002 | WO2002064110A2 Carotenoid-loaded liposomes |
| 08/22/2002 | WO2002064109A2 Mucoadhesive pharmaceutical formulations |
| 08/22/2002 | WO2002064108A2 Delivery of biologically active agents |
| 08/22/2002 | WO2002064093A2 Stabilized pharmaceutical and thyroid hormone compositions and method of preparation |
| 08/22/2002 | WO2002064089A2 Methods of preventing ventilator associated pneumonia by oral administration of antimicrobial ib-367 peptides |
| 08/22/2002 | WO2002064014A2 Endomural therapy |
| 08/22/2002 | WO2002063982A1 Composition and method for smoke detoxification |
| 08/22/2002 | WO2002053583A3 Amphipathic peptides and their use for transferring substances of interest into cells |
| 08/22/2002 | WO2002041874A3 Granulation process |
| 08/22/2002 | WO2002032404A3 Nanoparticles |
| 08/22/2002 | WO2002024143A3 Treating microbial infection of skin lesions |
| 08/22/2002 | WO2002017883A3 Milled particles |
| 08/22/2002 | WO2002015959A3 Compounds and compositions for delivering active agents |
| 08/22/2002 | WO2002015939A3 Calycins |
| 08/22/2002 | WO2002004008A3 Methods of therapy with thrombin derived peptides |
| 08/22/2002 | WO2002002773A3 Dual specificity antibodies and methods of making and using |
| 08/22/2002 | WO2000035423A9 Biodegradable polymer encapsulated serotonin receptor antagonist and method for preparing the same |
| 08/22/2002 | WO2000032239A9 Hapten-carrier conjugates for treating and preventing nicotine addiction |
| 08/22/2002 | WO1999063992A9 Novel calcium channel drugs and uses |
| 08/22/2002 | US20020115833 Glycoprotein for use in the treatment of kidney and blood disorders |
| 08/22/2002 | US20020115824 Receptor-mediated uptake of peptides that bind the human transferrin receptor |
| 08/22/2002 | US20020115716 Oral low dose butyrate compositions |
| 08/22/2002 | US20020115690 Free of alcohol and propylene glycol; surfactant; polyethylene glycol solvent having a mean molecular weight of greater than 300 but lower than 600 |
| 08/22/2002 | US20020115686 Organic compounds |
| 08/22/2002 | US20020115645 Stabilized aqueous suspensions for parenteral use |
| 08/22/2002 | US20020115596 Conjugates useful in the treatment of prostate cancer |
| 08/22/2002 | US20020115595 Bioactive agent is covalently conjugated to an organocobalt complex's cobalt atom through a non-reactive atom in the bioactive agent molecule such as peptide, protein, nucleic acid and analogues |
| 08/22/2002 | US20020115592 And optionally aprotinin, in a nonaqueous hydrophilic medium of an alcohol and a cosolvent, in association with a medium chain partial glyceride, optionally in admixture a long-chain polyoxyethylene glycol; fine suspension |
| 08/22/2002 | US20020115588 Dry powder of parathyroid hormone suitable for inhalation of specified particle size in diameters; treating osteoporosis |
| 08/22/2002 | US20020115216 Cationic polymer; for use as tool in genetic engineering |
| 08/22/2002 | US20020115140 Nucleotide sequences coding preferential polypeptide for use in treatment of immmunological defects |
| 08/22/2002 | US20020115112 Neutrokine-alpha and Neutrokine-alpha splice variant |
| 08/22/2002 | US20020115061 Peptides for inducing cytotoxic t lymphocyte responses to hepatitis c viris |
| 08/22/2002 | US20020114867 Pigmenting a food or foodstuff combining in a source of feed, a carotenoid ester for e.g., methyl beta-apo-8'- carotenoate, n-propyl beta-apo-8'-carotenoate, n-butyl beta-apo-8'-carotenoate, isobutyl beta-apo-8'-carotenoate, etc. |
| 08/22/2002 | US20020114849 Topically applied formulation capable of treating subcutaneous tissue comprising an alkali metal hypohalite (AMH); for therapy of microbial infection; arthritis and/or gout; hemorrhoids |
| 08/22/2002 | US20020114844 Particle formation methods and their products |
| 08/22/2002 | US20020114843 Placing the quantity of microparticles into a container; maintaining the microparticles at a conditioning temperature for a period of time |
| 08/22/2002 | US20020114841 Composition and method |
| 08/22/2002 | US20020114839 Fenofibrate pharmaceutical composition having high bioavailability and method for preparing it |
| 08/22/2002 | US20020114837 Galenic composition for low bioavailability medicaments |
| 08/22/2002 | US20020114836 Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof |
| 08/22/2002 | US20020114828 For facilitating the transfer of nucleic acids into cells; gene therapy; transfection |
| 08/22/2002 | US20020114820 Products for topical applications comprising oil bodies |
| 08/22/2002 | US20020114813 Comprising target cell specific portion and enzymatically active portion capable of generating cyanide from a cyanogenic pro-drug; treatment of bladder cancer |
| 08/22/2002 | US20020114808 Methods and compositions for increasing the target-specific toxicity of a chemotherapy drug |
| 08/22/2002 | US20020114803 Compositions and methods for enhancing receptor-mediated cellular internalization |
| 08/22/2002 | US20020114798 Stable enzymatic wound debrider |